Sequentify For Profit
Sequentify develops genomic samples processing products and technologies for Next-Gen Sequencing. The company offers the InfiniSeq Workflow, which is a solution for swift, effortless, and budget-friendly targeted NGS library preparation. Their solution plays a pivotal role in paving the way for a significant reduction in the cost per sample, enabling genomic diagnostics and therapeutics at a population-wide scale. The company is ISO13485 accredited, and all Sequentify products are designated as RUO and intended for research use only. Contact info: Sequentify Ltd., 10 Moti Kind, St, 5th Floor, Rehovot, Israel 7638519, hello@sequentify.com.
Total Funding:
7000000
Headquarters:
Rehovot, HaMerkaz, Israel
Funding Status:
Seed
Employee Number:
11-50
Last Funding Type:
Grant
Technology:
Big data
Last Funding Date:
2022-10-31
Investors Number:
2
Founded Date:
2021-01-01
Industry:
Deep Diagnostics